Milestone Pharmaceuticals... (MIST)
2.04
-0.02 (-0.97%)
At close: Feb 21, 2025, 3:47 PM
Milestone Pharmaceuticals Income Statement
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 1M | 5M | 15M | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 480K | n/a | 376K | 236K | 10K | 8K |
| Gross Profit | 1M | 4.52M | 15M | -376K | -236K | -10K | -8K |
| Operating Income | -61.1M | -59.64M | -43.07M | -50.71M | -57.88M | -23.82M | -8.27M |
| Interest Income | 3.97M | 1.25M | 220K | 726K | 2.6M | 711K | 186K |
| Pretax Income | -59.69M | -58.39M | -42.85M | -49.98M | -55.28M | -23.11M | -8.08M |
| Net Income | -59.69M | -57.13M | -42.63M | -49.97M | -55.23M | -23.18M | -8.09M |
| Selling & General & Admin | 31.05M | 24.81M | 19.4M | 16.22M | 15.9M | 6.97M | 2.63M |
| Research & Development | 31.05M | 39.83M | 38.67M | 34.49M | 41.98M | 16.85M | 5.64M |
| Other Expenses | n/a | n/a | 7M | n/a | n/a | n/a | n/a |
| Operating Expenses | 62.1M | 64.64M | 58.07M | 50.71M | 57.88M | 23.82M | 8.27M |
| Interest Expense | 2.55M | n/a | n/a | 726K | 2.6M | n/a | n/a |
| Selling & Marketing Expenses | 15.11M | 9.1M | 7M | 5.94M | 8.89M | 3.92M | 1.13M |
| Cost & Expenses | 62.1M | 64.64M | 58.07M | 50.71M | 57.88M | 23.82M | 8.27M |
| Income Tax | n/a | -1.25M | -220K | -17K | -56K | 74K | 4K |
| Shares Outstanding (Basic) | 42.96M | 42.45M | 41.83M | 29.34M | 15.78M | 23.65M | 23.65M |
| Shares Outstanding (Diluted) | 42.96M | 42.45M | 41.83M | 29.34M | 15.78M | 23.65M | 23.65M |
| EPS (Basic) | -1.39 | -1.35 | -1.02 | -1.7 | -3.5 | -0.98 | -0.34 |
| EPS (Diluted) | -1.39 | -1.35 | -1.02 | -1.7 | -3.5 | -0.98 | -0.34 |
| EBITDA | -56.84M | -58.36M | -42.98M | -50.71M | -57.88M | -23.36M | -8.26M |
| Depreciation & Amortization | 92K | 480K | 362K | 376K | 236K | 10K | 8K |